| 
    
    
    
            
                Khalil  EL Khatabi   , Ilham  Aanouz, Marwa  Alaqarbeh, Mohammed Aziz Ajana, Tahar  Lakhlifi, Mohammed  Bouachrine*    
    
    
        
     Molecular docking was performed to explore the binding affinity of the 12 selected molecules in the target enzyme and then evaluated for in silico ADMET properties. The best hits were subjected to molecular dynamics simulation. 
     | 
			| 
    
    
    
            
                Jaleh  Barar*    
    
    
        
    The vast knowledge about the pathways that regulate the virus entry and molecular signaling of the pathogenesis of coronavirus are the key factor for the development of de novo nanoscaled diagnostic/therapeutic strategies.
     | 
			| 
    
    
    
            
                Mohammad Hossein Ahmadi*    
    
    
        
    A schematic representation of the application of viral interference phenomenon in prophylaxis of COVID-19. The viral interference is a competition phenomenon by which a primary virus infecting a cell prohibits the infection of the same cell by another (secondary) virus.
     | 
			| 
    
    
    
            
                Sajad  Khiali   , Afra  Rezagholizadeh   , Taher  Entezari-Maleki*    
    
    
        
    In the present perspective piece, three possible mechanisms of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an oncogenic virus in the lung have been discussed.
     | 
			| 
    
    
    
            
                Yang  Han   , Zhilong  Jia*   , Jinlong  Shi, Weidong  Wang*, Kunlun  He*
             
    
    
        
    The enrichment of several other pathogens, immunomodulatory probiotics (lactic acid or butyrate producers), and TMV in the COVID-19 group suggests a complex and active lung microbiota disorder.
     | 
			| 
    
            
                Original Research 
                COVID-19
             
            
                Mohammad Mostafa Pourseif   , Sepideh  Parvizpour, Behzad  Jafari, Jaber  Dehghani   , Behrouz  Naghili, Yadollah  Omidi*    
    
    
        
    Immunodominant T-cell epitopes of SARS-CoV-2 spike protein with the highest population coverage were predicted by analyzing peptide binders and consensus rank (CR) score. Multi-method B-cell epitope prediction approach was used to find B-cell immunodominant regions of spike protein. Upon the high immune-potent regions of the antigen(s), self-amplifying mRNA and peptide-based vaccines were designed. 
 | 
			| 
    
    
    
            
                Ysrafil  Ysrafil*   , Zulfiayu  Sapiun   , Indwiani  Astuti   , Mohammad Anas Anasiru, Nangsih Sulastri Slamet   , Hartati  Hartati   , Fadli  Husain, Sukmawati Ahmad Damiti    
    
    
        
    The two designed and constructed multiepitope vaccine have good characteristics and may have the potential to activate humoral and cellular immune responses against SARS-CoV-2. Further research is worth considering to confirm the findings of this study. 
     | 
			| 
    
    
    
            
                Maryam  Sayahinouri   , Sahar  Mashayekhi Firouz   , Amin  Ebrahimi Sadrabadi   , Mina  Masoudnia   , Mahnaz  Abdolahi   , Fatemeh  Jafarzadeh   , Meshkat  Nouripour   , Sana  Mirzazadeh   , Nazanin  Zangeneh   , Arsalan  Jalili*   , Nasser  Aghdami    
    
    
        
    In COVID-19 infection, the various functions of immune cells lead to defense or failure against the virus. Cell therapy is of great importance as a new treatment for COVID-19 infection. Therefore, in this review, we have dealt with the function of immune cells against the SARS-Cov-2 virus and new treatment methods for this disease with the help of different cell types
     | 
			| 
    
    
    
            
                Ysrafil  Ysrafil   , Arlan K. Imran, Prisca Syafriani Wicita, Vyani  Kamba, Fihrina  Mohamad, Ismail  Ismail, Ayyub Harly Nurung, Noviyanty Indjar Gama, Sari Eka Pratiwi, Indwiani  Astuti   , Firzan  Nainu, Talha Bin Emran
             | 
			| 
    
    
    
            
                Sahar  Farajnia   , Nazli  Khajenasiri, Safar  Farajnia*   , Farzin  Seyrafi, Nasim  Bakhtiyari
             | 
			| 
    
    
    
            
                Farnaz  Naeimzadeh   , Armin  Sadeghi   , Seiedhadi  Saghaleini   , Parvin  Sarbakhsh   , Ata  Mahmoodpoor   , Afshin  Gharekhani*    |